Ananym Capital Management LP Has $15.07 Million Stock Holdings in Sotera Health Company $SHC

Key Points

• Ananym Capital Management LP increased its stake in Sotera Health Company by 29.3%, acquiring 292,779 shares in the first quarter, bringing their total ownership to 1,292,779 shares worth approximately $15.07 million.
• Analysts have recently upgraded Sotera Health's stock rating, with Goldman Sachs changing it from "neutral" to "buy" and raising the price target from $14.00 to $17.00, while Barclays reaffirmed an "overweight" rating.
• The company reported earnings of $0.20 per share, surpassing analyst expectations, with revenue rising 6.4% year-over-year to $294.34 million in its latest quarterly results.

Ananym Capital Management LP raised its position in shares of Sotera Health Company (NASDAQ:SHC - Free Report) by 29.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,292,779 shares of the company's stock after purchasing an additional 292,779 shares during the period. Sotera Health accounts for about 7.5% of Ananym Capital Management LP's investment portfolio, making the stock its 6th largest position. Ananym Capital Management LP owned approximately 0.46% of Sotera Health worth $15,074,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the company. Principal Financial Group Inc. raised its stake in shares of Sotera Health by 0.3% in the 1st quarter. Principal Financial Group Inc. now owns 352,388 shares of the company's stock valued at $4,109,000 after acquiring an additional 1,037 shares in the last quarter. New York State Teachers Retirement System raised its stake in shares of Sotera Health by 1.9% in the 1st quarter. New York State Teachers Retirement System now owns 59,273 shares of the company's stock valued at $691,000 after acquiring an additional 1,100 shares in the last quarter. Tower Research Capital LLC TRC raised its stake in shares of Sotera Health by 37.8% in the 4th quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after acquiring an additional 1,640 shares in the last quarter. Quarry LP bought a new position in shares of Sotera Health in the 4th quarter valued at approximately $28,000. Finally, Caitong International Asset Management Co. Ltd raised its stake in shares of Sotera Health by 3,690.1% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 2,691 shares of the company's stock valued at $31,000 after acquiring an additional 2,620 shares in the last quarter. 91.03% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the company. Barclays reissued an "overweight" rating on shares of Sotera Health in a research note on Friday, August 8th. The Goldman Sachs Group raised Sotera Health from a "neutral" rating to a "buy" rating and raised their target price for the company from $14.00 to $17.00 in a report on Monday, May 5th. Finally, Wall Street Zen raised Sotera Health from a "buy" rating to a "strong-buy" rating in a report on Saturday, August 16th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, Sotera Health currently has a consensus rating of "Moderate Buy" and an average price target of $16.00.

Sotera Health Price Performance

SHC traded down $0.21 during trading on Tuesday, hitting $16.16. The company's stock had a trading volume of 1,396,244 shares, compared to its average volume of 1,718,861. The firm's 50 day moving average price is $13.08 and its two-hundred day moving average price is $12.30. The company has a quick ratio of 2.23, a current ratio of 2.47 and a debt-to-equity ratio of 4.49. Sotera Health Company has a 12 month low of $9.53 and a 12 month high of $17.08. The stock has a market capitalization of $4.59 billion, a price-to-earnings ratio of 202.03 and a beta of 1.84.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Friday, August 8th. The company reported $0.20 earnings per share for the quarter, topping analysts' consensus estimates of $0.17 by $0.03. The company had revenue of $294.34 million during the quarter, compared to the consensus estimate of $275.81 million. Sotera Health had a return on equity of 39.42% and a net margin of 2.14%.The firm's quarterly revenue was up 6.4% on a year-over-year basis. During the same quarter in the previous year, the company posted $0.19 earnings per share. Sotera Health has set its FY 2025 guidance at 0.750-0.820 EPS. Sell-side analysts forecast that Sotera Health Company will post 0.61 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Michael P. Rutz sold 126,611 shares of the company's stock in a transaction dated Friday, August 22nd. The stock was sold at an average price of $16.38, for a total value of $2,073,888.18. Following the completion of the sale, the insider owned 450,204 shares in the company, valued at approximately $7,374,341.52. This represents a 21.95% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this link. Corporate insiders own 55.12% of the company's stock.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.